Researchers test tailored drug doses for diabetics with damaged livers

NCT ID NCT07439536

Summary

This study tested whether using computer models to adjust the doses of two common medications (sitagliptin for diabetes and duloxetine for nerve pain) could make them safer and more effective for people who have both diabetes and liver cirrhosis. It involved 64 adult patients with these conditions over three months. The goal was to find better dosing rules for these patients, as standard doses might not be right when the liver is not working properly.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER CIRRHOSIS WITH DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Kafr El-Sheikh University

    Cairo, Kafrelsheikh, 33511, Egypt

Conditions

Explore the condition pages connected to this study.